<DOC>
	<DOCNO>NCT01530295</DOCNO>
	<brief_summary>Effect Radical Prostatectomy Combined Neoadjuvant Adjuvant Chemotherapy Patients High Risk Prostate Cancer . The purpose study evaluate whether neoajuvant adjuvant docetaxel prednisone effective treatment high risk localize prostate cancer .</brief_summary>
	<brief_title>Biochemical Recurrence Rate Radical Prostatectomy Combined With Neoadjuvant Adjuvant Chemotherapy High Risk Prostate Cancer</brief_title>
	<detailed_description>The purpose study evaluate whether neoajuvant adjuvant docetaxel prednisone effective treatment high risk localize prostate cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Prostate Cancer PSA &gt; 20 OR Clinical Stage &gt; T2C OR GS &gt; 7</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>